Study of the NSCLC microenvironment may help answer key clinical questions including identifying predictors of benefit from PD-(L)1 treatment and defining rational combination therapies; herein we present findings from a selection of studies primarily employing MAB methodologies to gain insights into the TME of NSCLC [48,49,50,51]. Here, CD274 is linked to non-small cell lung carcinoma.